Ubs Group Ag Instil Bio, Inc. Transaction History

Ubs Group Ag

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	BUY	$0.4 - $0.63 $8 - $12	20 Added 4.93%	426 $0
Q2 2023 Aug 11, 2023	SELL	$0.51 - $0.67 $12,710 - $16,697	-24,922 Reduced 98.4%	406 $0
Q1 2023 May 12, 2023	BUY	$0.6 - $0.91 $3,523 - $5,344	5,873 Added 30.19%	25,328 $16,000
Q4 2022 Feb 08, 2023	BUY	$0.48 - $5.33 $9,187 - $102,016	19,140 Added 6076.19%	19,455 $12,000
Q3 2022 Nov 10, 2022	BUY	$4.65 - $7.37 $1,464 - $2,321	315 New	315 $1,000
Q2 2022 Aug 10, 2022	SELL	$4.21 - $11.15 $113 - $301	-27 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$8.48 - $18.1 $89,302 - $190,611	-10,531 Reduced 99.74%	27 $0
Q4 2021 Feb 14, 2022	BUY	$15.37 - $22.5 $162,276 - $237,555	10,558 New	10,558 $181,000
Q3 2021 Nov 15, 2021	SELL	$15.05 - $23.28 $10,745 - $16,621	-714 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$15.31 - $24.63 $10,931 - $17,585	714 New	714 $14,000

1.9M

Ticker TIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 129,694,000
Market Cap $2.67B
Description
Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small ce...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.